IRIDEX (IRIX) Set to Announce Quarterly Earnings on Tuesday

IRIDEX (NASDAQ:IRIX) will be posting its quarterly earnings results after the market closes on Tuesday, May 14th. Analysts expect IRIDEX to post earnings of ($0.12) per share for the quarter.

IRIDEX (NASDAQ:IRIX) last issued its earnings results on Tuesday, March 26th. The medical equipment provider reported ($0.18) EPS for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.13). IRIDEX had a negative return on equity of 75.18% and a negative net margin of 18.45%. The company had revenue of $12.46 million during the quarter, compared to the consensus estimate of $14.90 million. On average, analysts expect IRIDEX to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

IRIDEX Stock Performance

IRIDEX stock opened at $2.84 on Thursday. The company has a 50 day moving average price of $2.85 and a 200-day moving average price of $2.71. The company has a market capitalization of $46.16 million, a PE ratio of -4.81 and a beta of 0.82. IRIDEX has a fifty-two week low of $1.31 and a fifty-two week high of $3.65.

Analyst Ratings Changes

Separately, StockNews.com initiated coverage on IRIDEX in a research report on Saturday, May 4th. They set a “hold” rating on the stock.

About IRIDEX

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.